Treatment of community acquired pneumonia: Assessment of antibiotic prescription

2^nd International Conference on Respiratory and Pulmonary Medicine

October 17-18, 2016 Chicago, USA

Saad Ghaus

University of Birmingham, UK

Posters & Accepted Abstracts: J Pulm Respir Med

Abstract :

Background: Community acquired pneumonia (CAP) affects 0.5-1% of UK adults annually, more than half of them are aged over 84. Hospitalized patients have 5-14% mortality, with annual costs exceeding �£400 million. The British Thoracic Society (BTS) have devised guidelines for CAP management. This involves documentation of severity using CURB65 score, and antibiotic prescription according to this score. Aim: To assess compliance with BTS guidelines (2009) in the Elderly Care ward of the Queen Elizabeth Hospital. Methods: Notes of geriatric patients treated for CAP during July, August and September were retrospectively studied for CURB65 score, antibiotic treatment, treatment duration and time before IV medication changed to oral (if applicable). The PICS online system was used as confirmation, and to identify if a prescribing note (for indication) had been issued. Data was analyzed on Microsoft Excel. Results: CURB65 recorded in 50% (24/48). Treatment was appropriate to the score in 54% of cases (no significant differences between scores, p=0.2393). Prescription note compliance was 69% and the average treatment duration was 6.21 (�±0.86) days. Conclusions: CURB65 was poorly documented in CAP. When documented, compliance with guidelines was poor. Prescriptions notes were absent in medical notes, and require improvement on PICS. Increased staff training for prescription notes and reaudit has been planned.

Biography :

Email: sxg239@bham.ac.uk